FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022506737> ?p ?o ?g. }

• W2022506737 endingPage "943" @default.
• W2022506737 startingPage "939" @default.
• W2022506737 abstract "Abstract The contribution of immune system to schizophrenia has been an important area of focus in schizophrenia research. Several genetic variants in the cytokine system have been associated with the pathogenesis of schizophrenia. The purpose of this study was to determine whether a pharmacogenetic relationship exists between a variable number of tandem repeats (VNTR) polymorphism in the interleukin‐1 receptor antagonist gene ( IL‐1RN ) and clinical improvement during antipsychotic treatment in patients with a first non‐affective psychotic episode. One hundred and fifty‐four subjects presenting with a first non‐affective psychotic episode were randomly assigned to treatment with haloperidol, risperidone, or olanzapine and rated with the Brief Psychiatric Rating Scale (BPRS), the Scale for the Assessment of Negative Symptoms (SANS) and the Scale for the Assessment of Positive Symptoms (SAPS) both at baseline and after 6 weeks of treatment. A control sample of 336 blood bank donors was also included. No differences in genotype or allele distributions were found between patients and controls. However, after controlling for baseline SANS scores, the genotype in the VNTR polymorphism in the IL‐1RN gene significantly predicted negative symptom improvement, accounting for approximately 7% of the variance (F = 5.23, df = 2, P = 0.006). The mean decrease in SANS scores was 58% for the IL‐1RN* 2 / 2 , 44% for the IL‐1RN* 1 / 2 , and 14% for the IL‐1RN* 1 / 1 subjects, respectively. These results suggest that the VNTR polymorphism in the IL‐1RN gene may be a useful predictor of negative symptom improvement in schizophrenic patients treated with antipsychotic drugs. © 2006 Wiley‐Liss, Inc." @default.
• W2022506737 created "2016-06-24" @default.
• W2022506737 creator A5006889688 @default.
• W2022506737 creator A5021174697 @default.
• W2022506737 creator A5027471452 @default.
• W2022506737 creator A5036401122 @default.
• W2022506737 creator A5039800222 @default.
• W2022506737 creator A5041851834 @default.
• W2022506737 creator A5084927731 @default.
• W2022506737 creator A5090672331 @default.
• W2022506737 date "2006-11-22" @default.
• W2022506737 modified "2023-10-18" @default.
• W2022506737 title "Association between the interleukin-1 receptor antagonist gene and negative symptom improvement during antipsychotic treatment" @default.
• W2022506737 cites W1525388955 @default.
• W2022506737 cites W1963531680 @default.
• W2022506737 cites W1963856882 @default.
• W2022506737 cites W1975842186 @default.
• W2022506737 cites W1981857027 @default.
• W2022506737 cites W1984882838 @default.
• W2022506737 cites W1989684475 @default.
• W2022506737 cites W1993877222 @default.
• W2022506737 cites W1995570133 @default.
• W2022506737 cites W2000681907 @default.
• W2022506737 cites W2000956334 @default.
• W2022506737 cites W2005104801 @default.
• W2022506737 cites W2006833690 @default.
• W2022506737 cites W2009999409 @default.
• W2022506737 cites W2020844317 @default.
• W2022506737 cites W2028726349 @default.
• W2022506737 cites W2032232644 @default.
• W2022506737 cites W2035859458 @default.
• W2022506737 cites W2040532973 @default.
• W2022506737 cites W2053818485 @default.
• W2022506737 cites W2063765445 @default.
• W2022506737 cites W2070914392 @default.
• W2022506737 cites W2073794680 @default.
• W2022506737 cites W2080978755 @default.
• W2022506737 cites W2093780531 @default.
• W2022506737 cites W2125466936 @default.
• W2022506737 cites W2130620798 @default.
• W2022506737 cites W2134144722 @default.
• W2022506737 cites W2136748552 @default.
• W2022506737 cites W2147024435 @default.
• W2022506737 cites W2151692644 @default.
• W2022506737 cites W2163835098 @default.
• W2022506737 cites W2170963398 @default.
• W2022506737 cites W2171149822 @default.
• W2022506737 cites W2324568215 @default.
• W2022506737 cites W2326680810 @default.
• W2022506737 cites W4239089989 @default.
• W2022506737 doi "https://doi.org/10.1002/ajmg.b.30405" @default.
• W2022506737 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16921503" @default.
• W2022506737 hasPublicationYear "2006" @default.
• W2022506737 type Work @default.
• W2022506737 sameAs 2022506737 @default.
• W2022506737 citedByCount "17" @default.
• W2022506737 countsByYear W20225067372012 @default.
• W2022506737 countsByYear W20225067372013 @default.
• W2022506737 countsByYear W20225067372015 @default.
• W2022506737 countsByYear W20225067372016 @default.
• W2022506737 countsByYear W20225067372018 @default.
• W2022506737 countsByYear W20225067372022 @default.
• W2022506737 crossrefType "journal-article" @default.
• W2022506737 hasAuthorship W2022506737A5006889688 @default.
• W2022506737 hasAuthorship W2022506737A5021174697 @default.
• W2022506737 hasAuthorship W2022506737A5027471452 @default.
• W2022506737 hasAuthorship W2022506737A5036401122 @default.
• W2022506737 hasAuthorship W2022506737A5039800222 @default.
• W2022506737 hasAuthorship W2022506737A5041851834 @default.
• W2022506737 hasAuthorship W2022506737A5084927731 @default.
• W2022506737 hasAuthorship W2022506737A5090672331 @default.
• W2022506737 hasConcept C104317684 @default.
• W2022506737 hasConcept C118552586 @default.
• W2022506737 hasConcept C126322002 @default.
• W2022506737 hasConcept C135763542 @default.
• W2022506737 hasConcept C138496976 @default.
• W2022506737 hasConcept C149737253 @default.
• W2022506737 hasConcept C15744967 @default.
• W2022506737 hasConcept C180754005 @default.
• W2022506737 hasConcept C189036908 @default.
• W2022506737 hasConcept C2776412080 @default.
• W2022506737 hasConcept C2776619155 @default.
• W2022506737 hasConcept C2778528637 @default.
• W2022506737 hasConcept C2779727114 @default.
• W2022506737 hasConcept C2780057945 @default.
• W2022506737 hasConcept C2780135775 @default.
• W2022506737 hasConcept C2780442968 @default.
• W2022506737 hasConcept C2780494398 @default.
• W2022506737 hasConcept C54355233 @default.
• W2022506737 hasConcept C71924100 @default.
• W2022506737 hasConcept C83849319 @default.
• W2022506737 hasConcept C86803240 @default.
• W2022506737 hasConceptScore W2022506737C104317684 @default.
• W2022506737 hasConceptScore W2022506737C118552586 @default.
• W2022506737 hasConceptScore W2022506737C126322002 @default.
• W2022506737 hasConceptScore W2022506737C135763542 @default.
• W2022506737 hasConceptScore W2022506737C138496976 @default.
• W2022506737 hasConceptScore W2022506737C149737253 @default.

• next